Magnesium is one of the most functionally influential minerals in human physiology, yet it remains one of the most overlooked.
It acts as a cofactor in more than 300 enzymatic reactions, meaning it is required for the chemical processes which keep cells alive.
From ATP energy production and nervous system signalling to muscle contraction – relaxation cycles, blood-sugar regulation, cardiovascular rhythm stability, and stress-response modulation, magnesium is foundational – not optional.
A key issue rarely discussed is that modern medications deplete magnesium far more commonly than magnesium interferes with medications.
Diuretics increase urinary magnesium loss. Proton pump inhibitors reduce absorption. Oral contraceptives, corticosteroids, certain antibiotics, and blood-pressure medications all shift magnesium status.
The result is a silent downward drift in intracellular magnesium levels, often misinterpreted as unrelated symptoms: muscle tightness, sleep disruption, anxiety, fatigue, headaches, irregular heartbeat sensations, low energy, and poor stress tolerance.
By contrast, magnesium itself has a very low interaction risk profile when used appropriately. It does not “override” medications; instead, it supports the physiological systems those medications often strain.
In clinical nutrition research, magnesium is considered a nutrient repletion strategy, not a pharmacological competitor.
Our research team felt compelled to develop a comprehensive magnesium course after repeatedly observing widespread subclinical deficiency patterns in both clinical datasets and population nutrition surveys.
Soil depletion, food processing, chronic stress, stimulant use, and medication exposure all converge. We believe this may represent an emerging magnesium insufficiency trend in New Zealand and globally – one which affects health on many levels including sleep quality, metabolic resilience, cardiovascular stability, and nervous system regulation.
Our course was created to equip NZ practitioners with evidence-based dosing logic, form selection guidance, and clinical application strategies.
It has now been endorsed by The Royal New Zealand College of General Practitioners (GP’s) and has also been submitted to professional pharmacy education channels, reflecting the growing recognition that magnesium literacy is becoming essential clinical knowledge.
We plan to continue our valuable magnesium research as years go by and will update the course when new research comes to light. We take our role as trusted health advisors very seriously and consider it an honour to support both the health/medical practitioners of New Zealand and the wider public in their education.
As always our science team are available to offer sleep medication safety advice.
Email: support@cleversleep.co.nz